How much is VelosBio worth in 2026?

VelosBio has a current valuation of N/A based on their Early Stage VC (Series B) round and secondary market data.

How much funding has VelosBio raised?

VelosBio has raised N/A in total funding across 1 funding rounds.

VelosBio

Pharmaceuticals

VelosBio valuation and funding history | Last updated: July 2, 2020 | 1 funding rounds

Current Valuation

N/A

As of July 2, 2020

Total Funding Raised

N/A

Across 1 round

Last Round

Early Stage VC (Series B)

$137.0M

Last Funding

Jul 2020

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
July 2, 2020	Early Stage VC (Series B)	$137.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

VelosBio is currently valued at N/A as of July 2, 2020.

Track VelosBio Valuation Updates

Get notified when VelosBio raises new funding or valuation changes

Explore More Data

Detailed analysis for VelosBio

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock VelosBio's valuation history, funding rounds, and growth metrics.

No credit card required

What is VelosBio Worth in 2026?

VelosBio is a leading private company in the Pharmaceuticals sector. Track VelosBio's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How VelosBio Valuation is Determined

Private company valuations like VelosBio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.